Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease ; volume:17 ; number:1 ; day:5 ; month:3 ; year:2022 ; pages:1-23 ; date:12.2022
Molecular neurodegeneration ; 17, Heft 1 (5.3.2022), 1-23, 12.2022
- Urheber
-
Bairamian, Diane
Sha, Sha
Rolhion, Nathalie
Sokol, Harry
Dorothée, Guillaume
Lemere, Cynthia A.
Krantic, Slavica
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-022-00522-2
- URN
-
urn:nbn:de:101:1-2022061719523395514800
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bairamian, Diane
- Sha, Sha
- Rolhion, Nathalie
- Sokol, Harry
- Dorothée, Guillaume
- Lemere, Cynthia A.
- Krantic, Slavica
- SpringerLink (Online service)
Ähnliche Objekte (12)
Alzheimer's disease: synaptic dysfunction and Aβ
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Circulating small extracellular vesicles in Alzheimer’s disease: a case–control study of neuro-inflammation and synaptic dysfunction
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
Early calcium dysregulation in Alzheimer’s disease: setting the stage for synaptic dysfunction
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Neddylation-dependent protein degradation is a nexus between synaptic insulin resistance, neuroinflammation and Alzheimer’s disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Alzheimer’s disease and gut microbiota
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s disease
Alzheimer's disease: synaptic dysfunction and Aβ
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Circulating small extracellular vesicles in Alzheimer’s disease: a case–control study of neuro-inflammation and synaptic dysfunction
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
Early calcium dysregulation in Alzheimer’s disease: setting the stage for synaptic dysfunction
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Neddylation-dependent protein degradation is a nexus between synaptic insulin resistance, neuroinflammation and Alzheimer’s disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Alzheimer’s disease and gut microbiota
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s disease
Alzheimer's disease: synaptic dysfunction and Aβ
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Circulating small extracellular vesicles in Alzheimer’s disease: a case–control study of neuro-inflammation and synaptic dysfunction
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
Early calcium dysregulation in Alzheimer’s disease: setting the stage for synaptic dysfunction
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Neddylation-dependent protein degradation is a nexus between synaptic insulin resistance, neuroinflammation and Alzheimer’s disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Alzheimer’s disease and gut microbiota